Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00176995
Status:
COMPLETED
Last Update Posted:
2006-11-13
First Post:
2005-09-12
Brief Title:
Effect of 15 Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae
Sponsor:
Hordinsky Maria K MD
Organization:
University of Minnesota
Study Overview
Official Title:
Phase II Open-Label Study of the Effect of 15 Eflornithine Hydrochloride Cream on Facial Hair of Men of African-American Descent With Pseudofolliculitis Barbae A Laser Scanning Confocal Microscopy and Video Imaging Study
Status:
COMPLETED
Status Verified Date:
2006-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is designed to gain insight into the mechanism of action of eflornithine hydrochloride in men and to aid in determining if this compound is deserving of further development for a pseudofolliculitis barbae indication This study will also provide knowledge which will be useful in designing future PFB trials in this indication is pursued
Detailed Description:
The proposed mechanism of action of eflornithine hydrochloride for treatment of hair growth is that it reduces the rate of cell growth within the hair follicle by inhibition of the enzyme ornithine decarboxylase ODC In preclinical studies eflornithine hydrochloride was shown to inhibit ODC and decrease hair mass In sheep systemic inhibition of ODC by eflornithine hydrochloride markedly altered not only the length and diameter of hair fibers but also the portion of the hair fiber cross-section occupied by paracortical cells which are primarily found in straight hairs In a Phase II study evaluating the effect of the drug in the treatment of female hirsutism it was anecdotally noted that those who also had PFB showed an improvement in this condition
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None